792 results
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 40, F:M 9:1 • Clinical ... life-threatening • Treatment ... sle #comparison #table ... #rheumatology #
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... medical diagrams, tables ... #pharmacology #table ... #medications #treatment
Medications for Treatment of Acute Gout
 - NSAIDs
 - Colchicine (Colcrys)
 - Corticosteroids
#Acute #Gout #Medications #Treatment
Medications for Treatment ... #Medications #Treatment ... Management #AAFP #Rheumatology
Thrombotic Microangiopathy - TTP VS HUS

Big picture points : Often hard to differentiate the two entities,
distinction has HUGE treatment ... and first-line treatment ... Comparison #Diagnosis #Table ... #Hematology
Common Biliary Diseases seen in the Emergency Room - Comparison Table:

Clinical Features, Labs, Imaging and Treatment

#Diagnosis
Room - Comparison Table ... : Clinical Features ... Labs, Imaging and Treatment ... BiliaryDiseases #Table
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Tobacco Cessation Treatment ... , Varenicline (tablet ... release (SR) (tablet ... Therapy #Comparison #Table
ANCA Vasculitis - GPA, MPA, Eosinophilic GPA

doi:10.1038/s41572-020-0204-y

#ANCA #Vasculitis #GPA #MPA #Eosinophilic #rheumatology #diagnosis #comparison #table
#Eosinophilic #rheumatology ... diagnosis #comparison #table
Central Retinal Artery Occlusion (CRAO) vs Central Retinal Vein Occlusion (CRVO) - A Comparison Table

Clinical Features,
- A Comparison Table ... Clinical Features ... Diagnosis and Treatment ... Vein #Comparison #Table
Gout Management in CKD
 • Colchicine
 • NSAID
 • Glucocorticoid
 • ACTH
 • Interleukin-1 Inhibitors

#Gout #Management
Management #CKD #rheumatology ... #treatment #comparison
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Tapering DMARDs - Treatment ... Guidelines #management #treatment ... #rheumatology